Position history for JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in ALNYLAM PHARMACEUTICALS INC
JACOBS LEVY EQUITY MANAGEMENT, INC holds 401,371 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $159.6M as of 2025-Q4. The position was decreased (-2.2% shares). ALNY represents 0.6% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.
Current Value
$159.6M
Current Shares
401,371
Total Value Change
+$156.4M
Total Shares Change
+388,088
Other major holders of ALNY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 401,371 |
-2.2% |
| $159.6M |
| 0.6% |
| $397.25 |
0 |
| 2025-Q3 | Increased | 410,342 | +2221.7% | $187.1M | 0.7% | $447.49 | 69 |
| 2025-Q2 | Decreased | 17,674 | -88.5% | $5.8M | 0.0% | $322.83 | 0 |
| 2025-Q1 | New | 152,970 | - | $41.3M | 0.2% | $268.46 | 48 |
| 2024-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $274.91 | 0 |
| 2024-Q2 | Decreased | 13,283 | -89.5% | $3.2M | 0.0% | $243.00 | 0 |